Nils Nickel

3.0k total citations
45 papers, 1.8k citations indexed

About

Nils Nickel is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, Nils Nickel has authored 45 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 19 papers in Cardiology and Cardiovascular Medicine and 7 papers in Internal Medicine. Recurrent topics in Nils Nickel's work include Pulmonary Hypertension Research and Treatments (32 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Nils Nickel is often cited by papers focused on Pulmonary Hypertension Research and Treatments (32 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Nils Nickel collaborates with scholars based in United States, Germany and France. Nils Nickel's co-authors include Marius M. Hoeper, Karen M. Olsson, Heiko Golpon, Tobias Welte, Volker Westerkamp, Jörn Tongers, Mark Greer, Lars Knudsen, Florian Laenger and Ulrich Lehmann and has published in prestigious journals such as The Journal of Experimental Medicine, Biomaterials and Circulation Research.

In The Last Decade

Nils Nickel

40 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nils Nickel United States 19 1.4k 821 363 210 188 45 1.8k
A. Morganti United States 13 1.7k 1.2× 622 0.8× 221 0.6× 234 1.1× 248 1.3× 26 2.5k
Neil Davie United Kingdom 18 1.6k 1.1× 880 1.1× 415 1.1× 270 1.3× 248 1.3× 41 2.0k
Andrei Seferian France 18 1.1k 0.8× 411 0.5× 272 0.7× 157 0.7× 260 1.4× 45 1.5k
Raphaël Thuillet France 17 909 0.6× 376 0.5× 318 0.9× 177 0.8× 121 0.6× 42 1.3k
Laurence Dewachter Belgium 19 987 0.7× 579 0.7× 360 1.0× 277 1.3× 91 0.5× 62 1.5k
Shunsuke Tatebe Japan 21 975 0.7× 808 1.0× 245 0.7× 201 1.0× 214 1.1× 80 1.5k
Zhuang Tian China 24 549 0.4× 399 0.5× 540 1.5× 255 1.2× 126 0.7× 140 1.6k
Bahil Ghanim Austria 27 1.0k 0.7× 234 0.3× 379 1.0× 336 1.6× 167 0.9× 60 1.7k
Yon K. Sung United States 14 793 0.6× 332 0.4× 200 0.6× 224 1.1× 62 0.3× 22 1.1k
Takeshi Ogo Japan 20 1.4k 1.0× 1.0k 1.3× 153 0.4× 131 0.6× 359 1.9× 72 1.8k

Countries citing papers authored by Nils Nickel

Since Specialization
Citations

This map shows the geographic impact of Nils Nickel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nils Nickel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nils Nickel more than expected).

Fields of papers citing papers by Nils Nickel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nils Nickel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nils Nickel. The network helps show where Nils Nickel may publish in the future.

Co-authorship network of co-authors of Nils Nickel

This figure shows the co-authorship network connecting the top 25 collaborators of Nils Nickel. A scholar is included among the top collaborators of Nils Nickel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nils Nickel. Nils Nickel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wahab, Riajul, Ali Keshavarz, Tamanna Islam, et al.. (2025). Microfluidic captured patient-derived circulating endothelial cells identify novel targets of pulmonary arterial hypertension. Biomaterials. 323. 123429–123429. 1 indexed citations
2.
3.
Rodríguez, José B. Cruz, et al.. (2023). Prognosis in Hispanic patient population with pulmonary arterial hypertension: An application of common risk stratification models. Pulmonary Circulation. 13(2). e12209–e12209. 4 indexed citations
4.
Nickel, Nils, et al.. (2023). Sleep apnea and cardiovascular risk. Current Opinion in Cardiology. 38(5). 456–461. 11 indexed citations
5.
Nickel, Nils, et al.. (2022). Cardiovascular Morbidity in Individuals with Impaired FEV1. Current Cardiology Reports. 24(3). 163–182. 3 indexed citations
6.
Nickel, Nils, et al.. (2021). Cefepime-Induced Encephalopathy in a High-Risk Patient With Renal Insufficiency and Cirrhosis. Cureus. 13(10). e18767–e18767. 3 indexed citations
7.
Nickel, Nils, Elya A. Shamskhou, David Condon, et al.. (2020). Anatomic, genetic and functional properties of the retinal circulation in pulmonary hypertension. Pulmonary Circulation. 10(2). 1–4. 7 indexed citations
8.
Nickel, Nils, Ke Yuan, Peter Dorfmüller, et al.. (2019). Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 201(2). 148–157. 57 indexed citations
9.
Nickel, Nils, Edda Spiekerkoetter, Mingxia Gu, et al.. (2015). Elafin Reverses Pulmonary Hypertension via Caveolin-1–Dependent Bone Morphogenetic Protein Signaling. American Journal of Respiratory and Critical Care Medicine. 191(11). 1273–1286. 102 indexed citations
10.
Diebold, Isabel, Jan K. Hennigs, Kazuya Miyagawa, et al.. (2015). BMPR2 Preserves Mitochondrial Function and DNA during Reoxygenation to Promote Endothelial Cell Survival and Reverse Pulmonary Hypertension. Cell Metabolism. 21(4). 596–608. 176 indexed citations
11.
Bockmeyer, Clemens L., Lavinia Maegel, Sabina Janciauskiene, et al.. (2012). Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression. The Journal of Heart and Lung Transplantation. 31(7). 764–772. 73 indexed citations
12.
Olsson, Karen M., Nils Nickel, Jörn Tongers, & Marius M. Hoeper. (2012). Atrial flutter and fibrillation in patients with pulmonary hypertension. International Journal of Cardiology. 167(5). 2300–2305. 130 indexed citations
13.
Nickel, Nils, Heiko Golpon, Mark Greer, et al.. (2011). The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension. European Respiratory Journal. 39(3). 589–596. 247 indexed citations
14.
Knudsen, Lars, Nils Nickel, Henning Tiede, et al.. (2011). Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy. BMC Pulmonary Medicine. 11(1). 56–56. 16 indexed citations
15.
Nickel, Nils, Danny Jonigk, Tibor Kempf, et al.. (2011). GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells. Respiratory Research. 12(1). 62–62. 84 indexed citations
16.
Jonigk, Danny, Heiko Golpon, Clemens L. Bockmeyer, et al.. (2011). Plexiform Lesions in Pulmonary Arterial Hypertension. American Journal Of Pathology. 179(1). 167–179. 131 indexed citations
17.
Kümpers, Philipp, Nils Nickel, Alexander Lukasz, et al.. (2010). Circulating angiopoietins in idiopathic pulmonary arterial hypertension. European Heart Journal. 31(18). 2291–2300. 92 indexed citations
18.
Lorenzen, Johan M., Nils Nickel, Robert S. Kramer, et al.. (2010). Osteopontin in Patients With Idiopathic Pulmonary Hypertension. CHEST Journal. 139(5). 1010–1017. 62 indexed citations
19.
Hoeper, Marius M., Henning Gall, Michael Halank, et al.. (2009). Long-term outcome with intravenous iloprost in pulmonary arterial hypertension. European Respiratory Journal. 34(1). 132–137. 71 indexed citations
20.
Nickel, Nils, Tibor Kempf, Jörn Tongers, et al.. (2008). Growth Differentiation Factor-15 in Idiopathic Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 178(5). 534–541. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026